Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.33
USPH's Cash to Debt is ranked higher than
75% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. USPH: 0.33 )
USPH' s 10-Year Cash to Debt Range
Min: 0.17   Max: 298.04
Current: 0.33

0.17
298.04
Equity to Asset 0.57
USPH's Equity to Asset is ranked higher than
84% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. USPH: 0.57 )
USPH' s 10-Year Equity to Asset Range
Min: 0.27   Max: 0.85
Current: 0.57

0.27
0.85
Interest Coverage 72.06
USPH's Interest Coverage is ranked higher than
87% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 5.04 vs. USPH: 72.06 )
USPH' s 10-Year Interest Coverage Range
Min: 2.29   Max: 9999.99
Current: 72.06

2.29
9999.99
F-Score: 6
Z-Score: 5.48
M-Score: -2.92
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 15.08
USPH's Operating margin (%) is ranked higher than
89% of the 309 Companies
in the Global Medical Care industry.

( Industry Median: 8.52 vs. USPH: 15.08 )
USPH' s 10-Year Operating margin (%) Range
Min: -10.47   Max: 20.94
Current: 15.08

-10.47
20.94
Net-margin (%) 6.71
USPH's Net-margin (%) is ranked higher than
83% of the 309 Companies
in the Global Medical Care industry.

( Industry Median: 4.94 vs. USPH: 6.71 )
USPH' s 10-Year Net-margin (%) Range
Min: -16.28   Max: 8.96
Current: 6.71

-16.28
8.96
ROE (%) 14.91
USPH's ROE (%) is ranked higher than
87% of the 289 Companies
in the Global Medical Care industry.

( Industry Median: 10.03 vs. USPH: 14.91 )
USPH' s 10-Year ROE (%) Range
Min: 10.36   Max: 39.04
Current: 14.91

10.36
39.04
ROA (%) 8.80
USPH's ROA (%) is ranked higher than
91% of the 310 Companies
in the Global Medical Care industry.

( Industry Median: 3.52 vs. USPH: 8.80 )
USPH' s 10-Year ROA (%) Range
Min: 4.61   Max: 23.91
Current: 8.8

4.61
23.91
ROC (Joel Greenblatt) (%) 136.92
USPH's ROC (Joel Greenblatt) (%) is ranked higher than
97% of the 309 Companies
in the Global Medical Care industry.

( Industry Median: 18.24 vs. USPH: 136.92 )
USPH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 30.77   Max: 128.82
Current: 136.92

30.77
128.82
Revenue Growth (3Y)(%) 7.10
USPH's Revenue Growth (3Y)(%) is ranked higher than
75% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. USPH: 7.10 )
USPH' s 10-Year Revenue Growth (3Y)(%) Range
Min: 7.1   Max: 29.5
Current: 7.1

7.1
29.5
EBITDA Growth (3Y)(%) 3.40
USPH's EBITDA Growth (3Y)(%) is ranked higher than
70% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. USPH: 3.40 )
USPH' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -0.7   Max: 28
Current: 3.4

-0.7
28
EPS Growth (3Y)(%) 3.20
USPH's EPS Growth (3Y)(%) is ranked higher than
70% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 13.80 vs. USPH: 3.20 )
USPH' s 10-Year EPS Growth (3Y)(%) Range
Min: -1.2   Max: 57.8
Current: 3.2

-1.2
57.8
» USPH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

USPH Guru Trades in Q4 2013

Jim Simons 599,000 sh (+4.96%)
Joel Greenblatt Sold Out
Chuck Royce 1,655,407 sh (-7.12%)
John Keeley 31,420 sh (-27.22%)
» More
Q1 2014

USPH Guru Trades in Q1 2014

Jim Simons 617,900 sh (+3.16%)
John Keeley 30,913 sh (-1.61%)
Chuck Royce 1,530,833 sh (-7.53%)
» More
Q2 2014

USPH Guru Trades in Q2 2014

Jim Simons 635,174 sh (+2.8%)
John Keeley Sold Out
Chuck Royce 1,455,929 sh (-4.89%)
» More
Q3 2014

USPH Guru Trades in Q3 2014

Jim Simons 628,874 sh (-0.99%)
Chuck Royce 1,265,210 sh (-13.1%)
» More
» Details

Insider Trades

Latest Guru Trades with USPH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
John Keeley 2014-06-30 Sold Out 0.02%$30.08 - $35.16 $ 40.2525%0
Joel Greenblatt 2013-12-31 Sold Out 0.04%$29.5 - $35.35 $ 40.2523%0
John Keeley 2013-12-31 Reduce -27.22%0.01%$29.5 - $35.35 $ 40.2523%31420
Joel Greenblatt 2013-09-30 New Buy0.04%$27.53 - $31.24 $ 40.2536%36550
Joel Greenblatt 2013-06-30 Sold Out 0.08%$22.97 - $31.37 $ 40.2552%0
Joel Greenblatt 2012-12-31 New Buy0.08%$22.72 - $27.94 $ 40.2553%47826
John Keeley 2012-09-30 Reduce -67.61%0.05%$23.95 - $28.01 $ 40.2553%40030
Joel Greenblatt 2012-06-30 Sold Out 0.02%$22.82 - $25.33 $ 40.2568%0
Joel Greenblatt 2012-03-31 New Buy0.02%$18.88 - $23.16 $ 40.25109%10643
John Keeley 2011-12-31 Add 36.02%0.01%$17.1 - $20.91 $ 40.25110%105740
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about US Physical Therapy Inc

USPH: A Small Cap with Big Cap Predictability
Aches, pains and partnerships. That’s the story of U.S. Physical Therapy (USPH). Aches and pains, not to mention recovery after surgery, represent a growing market as the population ages, and younger generations hit the tennis courts and running tracks. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 24.90
USPH's P/E(ttm) is ranked higher than
81% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 44.70 vs. USPH: 24.90 )
USPH' s 10-Year P/E(ttm) Range
Min: 8.86   Max: 33.21
Current: 24.9

8.86
33.21
P/B 3.48
USPH's P/B is ranked higher than
69% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 2.93 vs. USPH: 3.48 )
USPH' s 10-Year P/B Range
Min: 1.12   Max: 4.47
Current: 3.48

1.12
4.47
P/S 1.67
USPH's P/S is ranked higher than
69% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. USPH: 1.67 )
USPH' s 10-Year P/S Range
Min: 0.49   Max: 1.99
Current: 1.67

0.49
1.99
PFCF 12.35
USPH's PFCF is ranked higher than
90% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 53.33 vs. USPH: 12.35 )
USPH' s 10-Year PFCF Range
Min: 3.33   Max: 53.59
Current: 12.35

3.33
53.59
EV-to-EBIT 12.33
USPH's EV-to-EBIT is ranked higher than
90% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 24.30 vs. USPH: 12.33 )
USPH' s 10-Year EV-to-EBIT Range
Min: 3.9   Max: 13.1
Current: 12.33

3.9
13.1
PEG 4.12
USPH's PEG is ranked higher than
87% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. USPH: 4.12 )
USPH' s 10-Year PEG Range
Min: 0.54   Max: 4.85
Current: 4.12

0.54
4.85
Shiller P/E 28.53
USPH's Shiller P/E is ranked higher than
86% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 2025.80 vs. USPH: 28.53 )
USPH' s 10-Year Shiller P/E Range
Min: 10.64   Max: 36.73
Current: 28.53

10.64
36.73
Current Ratio 2.59
USPH's Current Ratio is ranked higher than
94% of the 310 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. USPH: 2.59 )
USPH' s 10-Year Current Ratio Range
Min: 1.63   Max: 16.64
Current: 2.59

1.63
16.64
Quick Ratio 2.59
USPH's Quick Ratio is ranked higher than
96% of the 310 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. USPH: 2.59 )
USPH' s 10-Year Quick Ratio Range
Min: 1.63   Max: 16.64
Current: 2.59

1.63
16.64

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.19
USPH's Dividend Yield is ranked lower than
63% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 1.51 vs. USPH: 1.19 )
USPH' s 10-Year Dividend Yield Range
Min: 0.31   Max: 1.74
Current: 1.19

0.31
1.74
Dividend Payout 0.30
USPH's Dividend Payout is ranked higher than
89% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. USPH: 0.30 )
USPH' s 10-Year Dividend Payout Range
Min: 0.12   Max: 5
Current: 0.3

0.12
5
Yield on cost (5-Year) 1.20
USPH's Yield on cost (5-Year) is ranked lower than
69% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 2.10 vs. USPH: 1.20 )
USPH' s 10-Year Yield on cost (5-Year) Range
Min: 0.31   Max: 1.74
Current: 1.2

0.31
1.74
Share Buyback Rate -0.60
USPH's Share Buyback Rate is ranked higher than
81% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: -1.40 vs. USPH: -0.60 )
USPH' s 10-Year Share Buyback Rate Range
Min: 2   Max: -6.3
Current: -0.6

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.99
USPH's Price/DCF (Projected) is ranked higher than
91% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 4.02 vs. USPH: 0.99 )
USPH' s 10-Year Price/DCF (Projected) Range
Min: 0.42   Max: 3.08
Current: 0.99

0.42
3.08
Price/Median PS Value 1.36
USPH's Price/Median PS Value is ranked higher than
66% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. USPH: 1.36 )
USPH' s 10-Year Price/Median PS Value Range
Min: 0.5   Max: 2.42
Current: 1.36

0.5
2.42
Price/Peter Lynch Fair Value 4.31
USPH's Price/Peter Lynch Fair Value is ranked higher than
87% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. USPH: 4.31 )
USPH' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.47   Max: 4.74
Current: 4.31

0.47
4.74
Earnings Yield (Greenblatt) 8.10
USPH's Earnings Yield (Greenblatt) is ranked higher than
90% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 4.60 vs. USPH: 8.10 )
USPH' s 10-Year Earnings Yield (Greenblatt) Range
Min: 7.7   Max: 25.6
Current: 8.1

7.7
25.6
Forward Rate of Return (Yacktman) 12.44
USPH's Forward Rate of Return (Yacktman) is ranked higher than
76% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 12.92 vs. USPH: 12.44 )
USPH' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 12   Max: 30.4
Current: 12.44

12
30.4

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:UPH.Germany,
U.S. Physical Therapy, Inc is incorporated in the state of Nevada in April 1992. The Company, together with its subsidiaries operates outpatient physical and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company operates 472 clinics in 43 states. There were 367 clinics operated under Clinic Partnerships and 105 were operated as Wholly-Owned Facilities. Of the 472 clinics, it developed 298 and acquired 174. Its clinics are concentrated in the states including: Tennessee, Texas, Michigan, Maryland, Washington, New Jersey, Wisconsin, Georgia, Arizona, Virginia, Indiana, Florida and Maine. It also managed 18 physical therapy practices for third parties, primarily physicians. U.S. Physical Therapy operates outpatient physical and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, preventative care, and rehabilitation of injured workers among others. The Company provides services at its clinics on an outpatient basis. Patients are usually treated for approximately one hour per day, two to three times a week, typically for two to six weeks. The Company generally charge for treatment on a per procedure basis. Medicare patients are charged based on prescribed time increments and Medicare billing standards. In addition, its clinics will developes individual maintenance and self-management exercise programs to be continued after treatment. It markets its therapy to physicians, including orthopedic surgeons, neurosurgeons, physiatrists, internal medicine physicians, podiatrists, occupational medicine physicians and general practitioners. The Company's operations are subject to federal and state laws.
» More Articles for USPH

Headlines

Articles On GuruFocus.com
USPH: A Small Cap with Big Cap Predictability Oct 08 2014 
Four 'Boring' Stocks to Consider Sep 30 2014 
comment on USPH Jan 24 2013 
12 Healthcare Dividend Stocks with Gaining Earnings Momentum Apr 02 2012 
U.S. Physical Therapy Inc. (USPH) CEO Christopher J Reading sells 25,000 Shares Mar 11 2011 
U.S. Physical Therapy Inc. (USPH) COO Glenn Mcdowell sells 10,614 Shares Mar 11 2011 
U.S. Physical Therapy Inc. Reports Operating Results (10-K) Mar 10 2011 
U.S. Physical Therapy Inc. (USPH) CFO Lawrance W Mcafee sells 5,000 Shares Mar 09 2011 
U.S. Physical Therapy Inc. (USPH) CFO Lawrance W Mcafee sells 15,000 Shares Mar 04 2011 
U.S. Physical Therapy Inc. (USPH) CFO Lawrance W Mcafee sells 5,000 Shares Dec 27 2010 

More From Other Websites
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K/A, Change in Directors or Principal Officers,... Dec 11 2014
USPh to Present at Oppenheimer 25th Annual Healthcare Conference Dec 08 2014
USPh to Present at Oppenheimer 25th Annual Healthcare Conference Dec 05 2014
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Dec 05 2014
U.S. Physical Therapy to Present at the Oppenheimer 25th Annual Healthcare Conference Dec 05 2014
U S PHYSICAL THERAPY INC /NV Financials Nov 14 2014
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Nov 12 2014
USPh to Present at the Stephens Fall Investment Conference Nov 11 2014
U.S. Physical Therapy to Present at the Stephens Fall Investment Conference Nov 11 2014
U S PHYSICAL THERAPY INC /NV Files SEC form 10-Q, Quarterly Report Nov 07 2014
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 06 2014
U.S. Physical Therapy Reports Third Quarter Results Nov 06 2014
Q3 2014 U.S. Physical Therapy Inc Earnings Release - Before Market Open Nov 06 2014
Amedisys Inc. (AMED) in Focus: Stock Surges 15.9% Oct 30 2014
USPh to Present at Investment and M&A Healthcare Conference Oct 14 2014
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Regulation FD Disclosure Oct 14 2014
U.S. Physical Therapy to Present at Investment and M&A Healthcare Conference Oct 14 2014
Gentiva Health Services (GTIV) Soars: Stock Rises 16.6% Oct 10 2014
U.S. Physical Therapy, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call for... Oct 09 2014
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Change in Directors or Principal Officers Aug 27 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK